Przejdź do zawartości
Merck

Assessment of protective effects of pheniramine maleate on reperfusion injury in lung after distant organ ischemia: a rat model.

Vascular and endovascular surgery (2013-02-05)
Orhan Gokalp, Ismail Yurekli, Muge Kiray, Alper Bagriyanik, Ufuk Yetkin, Banu Sarer Yurekli, Serkan Gur, Murat Aksun, Ismail Safa Satoglu, Gamze Gokalp, Ali Gurbuz
ABSTRAKT

The aim of this study is to investigate the protective effects of methylprednisolone (MP) and pheniramine maleate (PM) on reperfusion injury of lungs developing after ischemia of the left lower extremity of rats. A total of 28 randomly selected male rats were divided into 4 groups, each consisting of 7 rats. Group 1 was the control group. Group 2 was the sham group (ischemia/reperfusion [I/R]). Rats in group 3 were subjected to I/R and given PM (Ph group) and rats in group 4 were subjected to I/R and given MP (Pn group). Malondialdehyde levels were significantly lower in Ph group than in I/R group (P < .05). Superoxide dismutase and glutathione peroxidase enzyme activities were found to be significantly higher in Ph group than in the I/R group (P < .05). Histological examination demonstrated that PM had protective effects against I/R injury. The PM has a protective effect against I/R injury in rat lung.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Pheniramine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Pheniramine maleate salt